Eisai Gets Positive Opinion From CHMP In European Union For Lecanemab In Early Alzheimer's Disease
Eisai Co., Ltd. (ESALF.PK) and Biogen Inc. (BIIB) announced a positive opinion has been received from the Committee for Medicinal ...
FiercePharma9h
EU regulators endorse meds from BMS, J&J, Eisai and more—plus a clutch of biosims
Now, it's up to the European Commission to confirm those potential green lights in the coming weeks and months.
Zacks.com on MSN9h
Biogen Partner Eisai Gets Positive CHMP Nod for Leqembi in Europe
Biogen Inc.’s BIIB Japan-based partner, Eisai announced that the European Medicines Agency’s (EMA) Committee for Medicinal ...
Business Insider16h
Biogen (BIIB) Gets a Buy from TD Cowen
Nadeau covers the Healthcare sector, focusing on stocks such as Biogen, Aura Biosciences Inc, and BioMarin Pharmaceutical. The word on The Street in general, suggests a Moderate Buy analyst consensus ...